![Ann Taylor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ann Taylor
Directeur/Bestuurslid bij TERNS PHARMACEUTICALS, INC.
Vermogen: - $ op 31-05-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
T. Johnson | M | - |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | - |
David Fellows | M | 67 | 4 jaar | |
Aaron Smith | M | - |
Unlearn.AI, Inc.
![]() Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | 7 jaar |
Charles Fisher | M | - |
Unlearn.AI, Inc.
![]() Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | 7 jaar |
Michael Young | M | - |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | - |
Bryan Yoon | M | 46 | 4 jaar | |
Jill Quigley | F | 49 | 4 jaar | |
Jonathan Walsh | M | - |
Unlearn.AI, Inc.
![]() Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | 7 jaar |
Jeffrey Kindler | M | 68 | 4 jaar | |
Amy Burroughs | F | 54 | - | |
Radhika Tripuraneni | M | 44 | 2 jaar | |
Mark Vignola | M | 47 | 4 jaar | |
Hong Bo Lu | M | 53 | 4 jaar | |
Carl Gordon | M | 59 | 6 jaar | |
Muz Mansuri | M | - |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | - |
Allyson Felix | F | - |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | - |
Mira Murati | F | - |
Unlearn.AI, Inc.
![]() Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | 1 jaar |
Ketan Patel | M | - |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | - |
Brendan Bulik-Sulivan | M | - |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | - |
Art Levin | M | - |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | - |
Jenna Urban | F | - | - | |
Graham Siegel | M | - |
Unlearn.AI, Inc.
![]() Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | - |
Emil T. Kuriakose | M | 44 | 1 jaar | |
Justin Ng | M | - | - | |
Melita Jung | F | 47 | - | |
Dylan Morris | M | - |
Unlearn.AI, Inc.
![]() Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | 2 jaar |
Francisco Gimenez | M | - |
Unlearn.AI, Inc.
![]() Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | - |
Eric N. Shiozaki | M | - |
Unlearn.AI, Inc.
![]() Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | - |
Jeffrey R. Jasper | M | - | 2 jaar | |
John Hamer | M | 66 |
Unlearn.AI, Inc.
![]() Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | - |
John Richards | M | 67 |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | - |
Clive Meanwell | M | 67 |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | 3 jaar |
Maximilian Meanwell | M | - |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Erin Quirk | M | 53 | 5 jaar | |
Bahija Jallal | M | 62 |
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 13 jaar |
Diana Chung | F | - | - | |
Senthil Sundaram | M | 46 | 3 jaar | |
Kerry Russell | M | - | 1 jaar | |
JoAnn Suzich | M | 68 |
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 2 jaar |
Jean-Charles Soria | M | 53 |
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 2 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 31 | 77.50% |
Canada | 9 | 22.50% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Ann Taylor
- Persoonlijk netwerk